J. Schafer, Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct, American Journal of Physiology - Renal Physiology, vol.283, issue.2, pp.221-235, 2002.
DOI : 10.1152/ajprenal.00068.2002

A. Leaf, F. Bartter, R. Santos, and O. Wrong, EVIDENCE IN MAN THAT URINARY ELECTROLYTE LOSS INDUCED BY PITRESSIN IS A FUNCTION OF WATER RETENTION 1, Journal of Clinical Investigation, vol.32, issue.9, pp.868-878, 1953.
DOI : 10.1172/JCI102805

M. Humphreys, R. Friedler, and L. Earley, Natriuresis produced by vasopressin or hemorrhage during water diuresis in the dog, Am J Physiol, vol.219, pp.658-665, 1970.

V. Buckalew and K. Dimond, Effect of vasopressin on sodium excretion and plasma antinatriferic activity in the dog, Am J Physiol, vol.231, pp.28-33, 1976.

R. Balment, M. Brimble, M. Forsling, and C. Musabayane, Natriuretic response of the rat to plasma concentrations of arginine vasopressin within the physiological range., The Journal of Physiology, vol.352, issue.1, pp.517-526, 1984.
DOI : 10.1113/jphysiol.1984.sp015307

J. Crofton, L. Share, R. Shade, C. Allen, and D. Tarnowski, Vasopressin in the rat with spontaneous hypertension, Am. J. Physiol, vol.235, pp.361-366, 1978.

M. Damgaard, P. Norsk, F. Gustafsson, J. Kanters, N. Christensen et al., Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure, AJP: Regulatory, Integrative and Comparative Physiology, vol.290, issue.5, pp.1294-1301, 2006.
DOI : 10.1152/ajpregu.00738.2005

G. Dibona, Sympathetic nervous system and the kidney in hypertension, Current Opinion in Nephrology and Hypertension, vol.11, issue.2, pp.197-200, 2002.
DOI : 10.1097/00041552-200203000-00011

F. Dunn, T. Brennan, A. Nelson, and G. Robertson, The Role of Blood Osmolality and Volume in Regulating Vasopressin Secretion in the Rat, Journal of Clinical Investigation, vol.52, issue.12, pp.3212-3219, 1973.
DOI : 10.1172/JCI107521

L. Earley, Sodium metabolism Clinical disorders of fluid and electrolyte metabolism, pp.95-119, 1972.

C. Ecelbarger, G. Kim, J. Terris, S. Masilamani, C. Mitchell et al., Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney, Am. J. Physiol. Renal Physiol, vol.279, pp.46-53, 2000.

P. Elliott, L. Walker, M. Little, J. Blair-west, R. Shade et al., Change in Salt Intake Affects Blood Pressure of Chimpanzees: Implications for Human Populations, Circulation, vol.116, issue.14, pp.1563-1568, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.675579

. Serradeil-le, C. Gal, J. Wagnon, C. Garcia, C. Lacour et al., Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors., Journal of Clinical Investigation, vol.92, issue.1, pp.224-231, 1993.
DOI : 10.1172/JCI116554

. Serradeil-le, C. Gal, J. Wagnon, J. Simiand, G. Griebel et al., Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2- methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl), a selective and orally active vasopressin V1b receptor antagonist, J. Pharmacol. Exp. Ther, vol.300, pp.1122-1130, 2002.

L. Share, J. Crofton, and Y. Ouchi, Vasopressin: Sexual Dimorphism in Secretion, Cardiovascular Actions and Hypertension, The American Journal of the Medical Sciences, vol.295, issue.4, pp.314-319, 1988.
DOI : 10.1097/00000441-198804000-00017

J. Simon, M. Brody, and B. Kasson, Characterization of a vasopressin-like peptide in rat and bovine blood vessels, Am. J. Physiol, vol.262, pp.799-805, 1992.

J. Song, X. Hu, S. Riazi, S. Tiwari, J. Wade et al., Regulation of blood pressure, the epithelial sodium channel (ENaC), and other key renal sodium transporters by chronic insulin infusion in rats, AJP: Renal Physiology, vol.290, issue.5, pp.1055-1064, 2006.
DOI : 10.1152/ajprenal.00108.2005

J. Staessen, W. Birkenhager, C. Bulpitt, R. Fagard, A. Fletcher et al., The relationship between blood pressure and sodium and potassium excretion during the day and at night, Journal of Hypertension, vol.11, issue.4, pp.443-447, 1993.
DOI : 10.1097/00004872-199304000-00016

S. Le, S. Ou-l-'origine, . Ethnique, . Implications, L. Dans et al., Difference in urine concentration according to gender and ethnicity : Possible involvement in the different susceptibility to various renal and cardiovascular diseases

. Tel, 33 1 42 34 68 47 15 rue de l'Ecole de Médecine Fax

. Paris and E. France, bankir@fer-a-moulin.inserm.fr d'IRC (étude T) [33]. Données fournies par le Dr

G. Etude, Données concernant six sujets sains (3 hommes et 3 femmes, pp.31-35

R. Etude, Données concernant 65 patients (21 -79 ans)

S. Etude, 17 -86 ans) ayant une fonction rénale normale ou diminuée de façon plus ou moins intense, sous régime alimentaire libre et dont les traitements habituels n'avaient pas été interrompus. Le but de l'étude intiale était de déterminer la réduction de la capacité de concentration urinaire et les taux, Cette étude concerne 148 sujetsAVP au cours de l'IRC [37]. Données fournies par le Pr. Paul Jungers

B. La-concentration-de-l, urine : évaluation directe ou indirecte Le volume d'urine des 24 h a été mesuré dans toutes les études (sauf l'étude G), mais U osm n

1. Quand, U. Na, U. K. , C. , and D. , une valeur estimée de U osm (= eU osm ) a été calculée grâce à la formule : eU osm =

L. Valeurs-sont-les-moyennes and ±. Esm, DM = sujets avec un diabète sucré; IRC = sujets avec une insuffisance rénale chronique. Le rapport hommes/femmes (H/F) pour chaque variable dans chaque étude a été calculé en utilisant les moyennes observées dans chaque sexe

. Cauc, = Sujets caucasiens; AA = Sujets afro-américains

R. 1. Daudon, M. Hennequin, C. Boujelben, G. Lacour, B. Jungers et al., Serial crystalluria determination and the risk of recurrence in calcium stone formers, Kidney International, vol.67, issue.5, pp.1934-1943, 2005.
DOI : 10.1111/j.1523-1755.2005.00292.x

J. H. Parks, R. Barsky, and F. L. Coe, Gender Differences in Seasonal Variation of Urine Stone Risk Factors, The Journal of Urology, vol.170, issue.2, pp.384-388, 2003.
DOI : 10.1097/01.ju.0000071721.91229.27

M. Zeier, U. Gafter, and E. Ritz, Renal function and renal disease in males or females - vive la petite difference, Nephrology Dialysis Transplantation, vol.13, issue.9, pp.2195-2198, 1998.
DOI : 10.1093/oxfordjournals.ndt.a027910

K. Sandberg and H. Ji, Sex and the renin angiotensin system: Implications for gender differences in the progression of kidney disease, Advances in Renal Replacement Therapy, vol.10, issue.1, pp.15-23, 2003.
DOI : 10.1053/jarr.2003.50006

J. Neugarten, A. Acharya, and S. R. Silbiger, Effect of gender on the progression of nondiabetic renal disease: a meta-analysis, J Am Soc Nephrol, vol.11, pp.319-329, 2000.

D. Reyes, S. Q. Lew, and P. L. Kimmel, Gender Differences in Hypertension and Kidney Disease, Medical Clinics of North America, vol.89, issue.3, pp.613-630, 2005.
DOI : 10.1016/j.mcna.2004.11.010

A. Remuzzi, S. Puntorieri, A. Mazzoleni, and G. Remuzzi, Sex related differences in glomerular ultrafiltration and proteinuria in Munich-Wistar rats, Kidney International, vol.34, issue.4, pp.481-486, 1988.
DOI : 10.1038/ki.1988.206

C. Baylis, Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor., Journal of Clinical Investigation, vol.94, issue.5, pp.1823-1829, 1994.
DOI : 10.1172/JCI117531

K. D. Stringer, R. Komers, S. A. Osman, T. T. Oyama, J. N. Lindsley et al., Gender hormones and the progression of experimental polycystic kidney disease, Kidney International, vol.68, issue.4, pp.1729-1739, 2005.
DOI : 10.1111/j.1523-1755.2005.00589.x

R. Gaskin, Diet, diabetes, hypertension and blacks, Ethn Dis, vol.9, pp.272-277, 1999.

B. I. Freedman, Susceptibility Genes for Hypertension and Renal Failure, Journal of the American Society of Nephrology, vol.14, issue.90002, pp.192-194, 2003.
DOI : 10.1097/01.ASN.0000070075.89996.4A

S. Li, D. D. Mcalpine, J. Liu, and A. J. Collins, Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors, Advances in Renal Replacement Therapy, vol.11, issue.1, pp.5-13, 2004.
DOI : 10.1053/j.arrt.2003.10.005

J. Perucca, N. Bouby, P. Valeix, and L. Bankir, Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease, AJP: Regulatory, Integrative and Comparative Physiology, vol.292, issue.2, pp.700-705, 2007.
DOI : 10.1152/ajpregu.00500.2006

L. Bankir, J. Perucca, and M. Weinberger, Ethnic Differences in Urine Concentration: Possible Relationship to Blood Pressure, Clinical Journal of the American Society of Nephrology, vol.2, issue.2, pp.304-312, 2007.
DOI : 10.2215/CJN.03401006

L. Eloy, J. P. Gr?feld, F. Bayle, B. Ramos-fremdo, and M. Trinh-trang-tan, Papillary plasma flow in rats, Pfl???gers Archiv European Journal of Physiology, vol.59, issue.Suppl II, pp.253-258, 1983.
DOI : 10.1007/BF00657161

O. Oudar, M. Elger, L. Bankir, D. Ganten, U. Ganten et al., Differences in Rat Kidney Morphology between Males, Females and Testosterone-Treated Females, Kidney and Blood Pressure Research, vol.14, issue.3, pp.92-102, 1991.
DOI : 10.1159/000173392

L. Share, J. T. Crofton, and Y. Ouchi, Vasopressin: Sexual Dimorphism in Secretion, Cardiovascular Actions and Hypertension, The American Journal of the Medical Sciences, vol.295, issue.4, pp.314-319, 1988.
DOI : 10.1097/00000441-198804000-00017

J. T. Crofton, H. Dustan, L. Share, and D. P. Brooks, Vasopressin secretion in normotensive black and white men and women on normal and low sodium diets, Journal of Endocrinology, vol.108, issue.2, pp.191-199, 1986.
DOI : 10.1677/joe.0.1080191

G. Bakris, M. Bursztyn, I. Gavras, M. Bresnahan, and H. Gavras, Role of vasopressin in essential hypertension, Journal of Hypertension, vol.15, issue.5, pp.545-550, 1997.
DOI : 10.1097/00004872-199715050-00011

M. Bursztyn, M. Bresnahan, I. Gavras, and H. Gavras, Pressor hormones in elderly hypertensive persons. Racial differences., Hypertension, vol.15, issue.2_Suppl, pp.88-92, 1990.
DOI : 10.1161/01.HYP.15.2_Suppl.I88

N. Bouby, S. Bachmann, D. Bichet, and L. Bankir, Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat, Am J Physiol, vol.258, pp.973-979, 1990.

N. Bouby, C. Hassler, and L. Bankir, Contribution of vasopressin to progression of chronic renal failure: Study in Brattleboro rats, Life Sciences, vol.65, issue.10, pp.991-1004, 1999.
DOI : 10.1016/S0024-3205(99)00330-6

P. Bardoux, H. Martin, M. Ahloulay, F. Schmitt, N. Bouby et al., Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: Study in vasopressin-deficient Brattleboro rats, Proceedings of the National Academy of Sciences, vol.96, issue.18, pp.10397-10402, 1999.
DOI : 10.1073/pnas.96.18.10397

S. Fernandes, P. Bruneval, A. Hagege, D. Heudes, S. Ghostine et al., Chronic V2 Vasopressin Receptor Stimulation Increases Basal Blood Pressure and Exacerbates Deoxycorticosterone Acetate-Salt Hypertension, Endocrinology, vol.143, issue.7, pp.2759-2766, 2002.
DOI : 10.1210/endo.143.7.8918

C. Serradeil-le-gal, C. Lacour, G. Valette, G. Garcia, L. Foulon et al., Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist., Journal of Clinical Investigation, vol.98, issue.12, pp.2729-2738, 1996.
DOI : 10.1172/JCI119098

Y. Yamamura, S. Nakamura, S. Itoh, T. Hirano, T. Onogawa et al., OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats, J Pharmacol Exp Ther, vol.287, pp.860-867, 1998.

. Serradeil-le and C. Gal, An overview of SR121463, a selective non-peptide vasopressin V(2) receptor antagonist, Cardiovasc Drug Rev, vol.19, pp.201-214, 2001.

A. Greenberg and J. G. Verbalis, Vasopressin receptor antagonists, Kidney International, vol.69, issue.12, pp.2124-2130, 2006.
DOI : 10.1038/sj.ki.5000432

R. Lemmens-gruber and M. Kamyar, Vasopressin antagonists, Cellular and Molecular Life Sciences, vol.63, issue.15, pp.1766-1779, 2006.
DOI : 10.1007/s00018-006-6054-2

L. Bankir, S. Fernandes, P. Bardoux, N. Bouby, and D. Bichet, Vasopressin-V2 Receptor Stimulation Reduces Sodium Excretion in Healthy Humans, Journal of the American Society of Nephrology, vol.16, issue.7, pp.1920-1928, 2005.
DOI : 10.1681/ASN.2004121079

D. G. Bichet, M. Razi, M. Lonergan, M. F. Arthus, V. Papukna et al., Hemodynamic and Coagulation Responses to 1-Desamino[8-D-Arginine] Vasopressin in Patients with Congenital Nephrogenic Diabetes Insipidus, New England Journal of Medicine, vol.318, issue.14, pp.881-887, 1988.
DOI : 10.1056/NEJM198804073181403

S. Hercberg, P. Galan, P. Preziosi, S. Bertrais, L. Mennen et al., The SU.VI.MAX Study, Archives of Internal Medicine, vol.164, issue.21, pp.2335-2342, 2004.
DOI : 10.1001/archinte.164.21.2335

URL : https://hal.archives-ouvertes.fr/hal-01346671

S. Q. Lew and J. P. Bosch, Effect of diet on creatinine clearance and excretion in young and elderly healthy subjects and in patients with renal disease, J Am Soc Nephrol, vol.2, pp.856-865, 1991.

F. C. Luft, C. E. Grim, N. Fineberg, and M. C. Weinberger, Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages, Circulation, vol.59, issue.4, pp.643-650, 1979.
DOI : 10.1161/01.CIR.59.4.643

F. M. Sacks, L. P. Svetkey, W. M. Vollmer, L. J. Appel, G. A. Bray et al., Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet, New England Journal of Medicine, vol.344, issue.1, pp.3-10, 2001.
DOI : 10.1056/NEJM200101043440101

M. H. Weinberger, J. Z. Miller, F. C. Luft, C. E. Grim, and N. S. Fineberg, Definitions and characteristics of sodium sensitivity and blood pressure resistance., Hypertension, vol.8, issue.6_Pt_2, pp.127-134, 1986.
DOI : 10.1161/01.HYP.8.6_Pt_2.II127

L. Bankir, N. Bouby, R. Ardaillou, D. G. Bichet, J. C. Dussaule et al., Progressive increase in plasma vasopressin (AVP) and decrease in urine concentrating ability in chronic renal failure (CRF): influence of primary disease (abstract), J Am Soc Nephrol, vol.3, p.733, 1992.

B. Bankir-lise, M. Pascale, D. Hervé, B. Olivier, and . Bernard, Too low urinary flow rate during the day: new factor possibly involved in hypertension and in the lack of nocturnal dipping (in French), Arch Mal Coeur Vaiss, vol.95, pp.751-754, 2002.

A. Hadj-aissa, L. Bankir, M. Fraysse, D. G. Bichet, M. Laville et al., Influence of the level of hydration on the renal response to a protein meal, Kidney International, vol.42, issue.5, pp.1207-1216, 1992.
DOI : 10.1038/ki.1992.406

L. A. Hebert, T. Greene, A. Levey, M. E. Falkenhain, and S. Klahr, High urine volume and low urine osmolality are risk factors for faster progression of renal disease, American Journal of Kidney Diseases, vol.41, issue.5, pp.962-971, 2003.
DOI : 10.1016/S0272-6386(03)00193-8

P. Namnum, K. Insogna, D. Baggish, and J. P. Hayslett, Evidence for bidirectional net movement of creatinine in the rat kidney, Am J Physiol, vol.244, pp.719-723, 1983.

O. Connel, J. Romeo, J. A. Mudge, and G. , Renal tubular secretion of creatinine in the dog, Am J Physiol, vol.203, pp.985-990, 1962.

A. M. Harvey and R. L. Malvin, Comparison of creatinine and inulin clearances in male and female rats, Am J Physiol, vol.209, pp.849-852, 1965.

F. J. Hoek, F. A. Kemperman, and R. T. Krediet, A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate, Nephrology Dialysis Transplantation, vol.18, issue.10, pp.2024-2031, 2003.
DOI : 10.1093/ndt/gfg349

A. S. Levey, J. Coresh, T. Greene, L. A. Stevens, Y. L. Zhang et al., Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate, Annals of Internal Medicine, vol.145, issue.4, pp.247-254, 2006.
DOI : 10.7326/0003-4819-145-4-200608150-00004

A. D. Rule, V. E. Torres, A. B. Chapman, J. J. Grantham, L. M. Guay-woodford et al., Comparison of Methods for Determining Renal Function Decline in Early Autosomal Dominant Polycystic Kidney Disease: The Consortium of Radiologic Imaging Studies of Polycystic Kidney Disease Cohort, Journal of the American Society of Nephrology, vol.17, issue.3, pp.854-862, 2006.
DOI : 10.1681/ASN.2005070697

A. W. Cowley, M. M. Skelton, and M. T. Velasquez, Sex differences in the endocrine predictors of essential hypertension. Vasopressin versus renin., Hypertension, vol.7, issue.3_Pt_2, pp.151-160, 1985.
DOI : 10.1161/01.HYP.7.3_Pt_2.I151

N. N. Izzat and J. P. Rosborough, Renal function in conscious dogs: Potential effect of gender on measurement, Research in Experimental Medicine, vol.13, issue.Suppl 41, pp.371-379, 1989.
DOI : 10.1007/BF01855043

R. L. Zerbe, J. Z. Miller, and G. Robertson, The reproductibility and heritability of individual differences in osmoregulatory function in normal human, J Lab Clin Med, vol.117, pp.51-59, 1991.

A. Ebner and F. Manz, Sex Difference of Urinary Osmolality in German Children, American Journal of Nephrology, vol.22, issue.4, pp.352-355, 2002.
DOI : 10.1159/000065226

A. G. Johnson, G. A. Crawford, D. Kelly, T. V. Nguyen, and A. Z. Gyory, Arginine Vasopressin and Osmolality in the Elderly, Journal of the American Geriatrics Society, vol.16, issue.Suppl, pp.399-404, 1994.
DOI : 10.1111/j.1532-5415.1994.tb07488.x

M. Ota, J. T. Crofton, H. Liu, G. Festavan, and L. Share, Increased plasma osmolality stimulates peripheral and central vasopressin release in male and female rats, Am J Physiol, vol.267, pp.923-928, 1994.

N. S. Stachenfeld, A. E. Splenser, W. L. Calzone, M. P. Taylor, and D. L. Keefe, Sex differences in osmotic regulation of AVP and renal sodium handling, J Appl Physiol, vol.91, pp.1893-1901, 2001.

L. Share, Y. X. Wang, J. Crofton, T. Saito, K. Kurokawa et al., Gender differences in the actions of vasopressin In : Neurohypophysis: recent progress of vasopressin and oxytocin research, pp.3-13, 1995.

Y. X. Wang, R. M. Edwards, P. Nambi, E. J. Stack, M. Pullen et al., Sex difference in the antidiuretic activity of vasopressin in the rat, Am J Physiol, vol.265, pp.1284-1290, 1993.

Y. X. Wang, J. T. Crofton, H. Liu, K. Sato, D. P. Brooks et al., Estradiol attenuates the antidiuretic action of vasopressin in ovariectomized rats, Am J Physiol, vol.268, pp.951-957, 1995.

T. Berl, A. Raz, H. Wald, J. Horowitz, and W. Czaczkes, Prostaglandin synthesis inhibition and the action of vasopressin: studies in man and rat, Am J Physiol, vol.232, pp.529-537, 1977.

J. J. Dixey, T. D. Williams, S. L. Lightman, A. F. Lant, and D. A. Brewerton, The effect of indomethacin on the renal response to arginine vasopressin in man, Clinical Science, vol.70, issue.5, pp.409-416, 1986.
DOI : 10.1042/cs0700409

W. Lieberthal, M. L. Vasilevsky, C. R. Valari, and N. G. Levinsky, Interactions between ADH and prostaglandins in isolated erythrocyte-perfused rat kidney, Am J Physiol, vol.252, pp.331-337, 1987.

N. Parekh, A. P. Zou, I. Jungling, K. Endlich, J. Sadowski et al., Sex differences in control of renal outer medullary circulation in rats: role of prostaglandins, Am J Physiol, vol.264, pp.629-636, 1993.

Y. X. Wang, J. T. Crofton, and L. Share, Sex differences in the cardiovascular and renal actions of vasopressin in conscious rats, Am J Physiol, vol.272, pp.370-376, 1997.

J. C. Sullivan, J. M. Sasser, D. M. Pollock, and J. S. Pollock, Sexual Dimorphism in Renal Production of Prostanoids in Spontaneously Hypertensive Rats, Hypertension, vol.45, issue.3, pp.406-411, 2005.
DOI : 10.1161/01.HYP.0000156879.83448.93

L. Bankir, C. Saha, and H. Pratt, Do blacks have a better ability to conserve water than whites? Possible consequences on blood pressure (abstract), Hypertension, vol.42, p.439, 2003.

M. Daudon, R. Donsimoni, C. Hennequin, S. Fellahi, L. Moel et al., Sex- and age-related composition of 10 617 calculi analyzed by infrared spectroscopy, Urological Research, vol.10, issue.5, pp.319-326, 1995.
DOI : 10.1007/BF00300021

K. K. Stamatelou, M. E. Francis, C. A. Jones, L. M. Nyberg, and G. C. Curhan, Time trends in reported prevalence of kidney stones in the United States, Kidney Int, vol.63, pp.1976-1994, 2003.

F. L. Coe, A. Evan, and E. Worcester, Kidney stone disease, Journal of Clinical Investigation, vol.115, issue.10, pp.2598-2608, 2005.
DOI : 10.1172/JCI26662

R. A. Hiatt, L. G. Dales, G. D. Friedman, and E. M. Hunkeler, FREQUENCY OF UROLITHIASIS IN A PREPAID MEDICAL CARE PROGRAM, American Journal of Epidemiology, vol.115, issue.2, pp.255-265, 1982.
DOI : 10.1093/oxfordjournals.aje.a113297

O. Mbonu, C. Attah, and I. Ikeakor, Urolithiasis in an African population, International Urology and Nephrology, vol.67, issue.4, pp.291-296, 1984.
DOI : 10.1007/BF02081863

I. Sarmina, J. P. Spirnak, and M. I. Resnick, Urinary lithiasis in the black population: an epidemiological study and review of the literature, J Urol, vol.138, pp.14-17, 1987.

N. Bouby, M. Ahloulay, E. Nsegbe, M. Dechaux, F. Schmitt et al., Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action, J Am Soc Nephrol, vol.7, pp.842-851, 1996.

A. B. Roald, O. Tenstad, and K. Aukland, The effect of AVP-V2 receptor stimulation on local GFR in the rat kidney, Acta Physiologica Scandinavica, vol.168, issue.2, pp.351-359, 2000.
DOI : 10.1046/j.1365-201X.2000.00663.x

L. Bankir and W. Kriz, Adaptation of the kidney to protein intake and to urine concentrating activity: Similar consequences in health and CRF, Kidney International, vol.47, issue.1, pp.7-24, 1995.
DOI : 10.1038/ki.1995.2

L. Bankir, N. Bouby, M. M. Trinh-trang-tan, M. Ahloulay, and D. Promeneur, Direct and indirect cost of urea excretion, Kidney International, vol.49, issue.6, pp.1598-1607, 1996.
DOI : 10.1038/ki.1996.232

L. Bankir and M. Trinh-trang-tan, Urea and the kidney, In : The Kidney, pp.637-679, 2000.

T. Sugiura, A. Yamauchi, H. Kitamura, Y. Matsuoka, M. Horio et al., High water intake ameliorates tubulointerstitial injury in rats with subtotal nephrectomy: Possible role of TGF-??, Kidney International, vol.55, issue.5, pp.1800-1810, 1999.
DOI : 10.1046/j.1523-1755.1999.00443.x

L. Bankir, M. Ahloulay, and P. Bardoux, Vasopressin and Diabetes mellitus, Nephron, vol.87, issue.1, pp.8-18, 2001.
DOI : 10.1159/000045879

P. Bardoux, D. G. Bichet, H. Martin, Y. Gallois, M. Marre et al., Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system, Nephrology Dialysis Transplantation, vol.18, issue.3, pp.497-506, 2003.
DOI : 10.1093/ndt/18.3.497

J. Gardes, M. F. Gonzalez, P. Corvol, and J. Menard, Influence of Converting Enzyme Inhibition on the Hormonal and Renal Adaptation to Hyper- and Hyponatraemic Dehydration, Journal of Hypertension, vol.4, issue.2, pp.189-196, 1986.
DOI : 10.1097/00004872-198604000-00008

E. B. Pedersen, H. Danielsen, M. Madsen, S. S. Sorensen, and O. O. Thomsen, Abnormal Vasopressin and Aldosterone Response to Furosemide in Essential Hypertension, Acta Medica Scandinavica, vol.11, issue.Suppl 636, pp.387-392, 1986.
DOI : 10.1111/j.0954-6820.1986.tb03328.x

B. D. Cowley, . Jr, J. C. Rupp, M. J. Muessel, and V. H. Gattone, Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats, American Journal of Kidney Diseases, vol.29, issue.2, pp.265-272, 1997.
DOI : 10.1016/S0272-6386(97)90039-1

J. J. Grantham, Mechanisms of progression in autosomal dominant polycystic kidney disease, Kidney Int Suppl, vol.63, pp.93-97, 1997.

V. H. Gattone, W. X. Harris, P. C. Torres, and V. E. , Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist, Nature Medicine, vol.9, issue.10, pp.1323-1326, 2003.
DOI : 10.1038/nm935

V. E. Torres, X. Wang, Q. Qian, S. Somlo, P. C. Harris et al., Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease, Nature Medicine, vol.10, issue.4, pp.363-364, 2004.
DOI : 10.1038/nm1004

X. Wang, V. Gattone, H. P. Torres, and V. E. , Effectiveness of Vasopressin V2 Receptor Antagonists OPC-31260 and OPC-41061 on Polycystic Kidney Disease Development in the PCK Rat, Journal of the American Society of Nephrology, vol.16, issue.4, pp.846-851, 2005.
DOI : 10.1681/ASN.2004121090

V. E. Torres, Vasopressin antagonists in polycystic kidney disease, Kidney International, vol.68, issue.5, pp.2405-2418, 2005.
DOI : 10.1111/j.1523-1755.2005.00703.x

P. Bardoux, P. Bruneval, D. Heudes, N. Bouby, and L. Bankir, Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats, Nephrology Dialysis Transplantation, vol.18, issue.9, pp.1755-1763, 2003.
DOI : 10.1093/ndt/gfg277

C. Nicco, M. Wittner, A. Distefano, S. Jounier, L. Bankir et al., Chronic Exposure to Vasopressin Upregulates ENaC and Sodium Transport in the Rat Renal Collecting Duct and Lung, Hypertension, vol.38, issue.5, pp.1143-1149, 2001.
DOI : 10.1161/hy1001.092641

J. A. Schafer, Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct, American Journal of Physiology - Renal Physiology, vol.283, issue.2, pp.221-235, 2002.
DOI : 10.1152/ajprenal.00068.2002

G. Choukroun, F. Schmitt, F. Martinez, T. Drueke, and L. Bankir, Low urine flow rate reduces the capacity to excrete a sodium load in man, Am J Physiol, vol.273, pp.1726-1733, 1997.

L. Bankir, B. Pouzet, G. Choukroun, N. Bouby, F. Schmitt et al., To concentrate the urine or to excrete sodium: two sometimes contradictory requirements

L. Bankir, Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects, Cardiovascular Research, vol.51, issue.3, pp.372-390, 2001.
DOI : 10.1016/S0008-6363(01)00328-5

P. Strazzullo and F. P. Cappuccio, Hypertension and kidney stones: hypotheses and implications, Semin Nephrol, vol.15, pp.519-525, 1995.

D. L. Gillen, F. L. Coe, and E. M. Worcester, Nephrolithiasis and Increased Blood Pressure Among Females With High Body Mass Index, American Journal of Kidney Diseases, vol.46, issue.2, pp.263-269, 2005.
DOI : 10.1053/j.ajkd.2005.04.030

L. Bankir, M. Bochud, M. Maillard, P. Bovet, C. Shamlaye et al., Impaired blood pressure dipping at night is associated with a deficit in sodium excretion during daytime due to a marked excess in reabsorption selectively in the distal nephron (abstract), J Am Soc Nephrol, vol.17, p.446, 2006.

J. H. Young, Y. P. Chang, J. D. Kim, J. P. Chretien, M. J. Klag et al., Differential Susceptibility to Hypertension Is Due to Selection during the Out-of-Africa Expansion, PLoS Genetics, vol.10, issue.6, p.82, 2005.
DOI : 10.1371/journal.pgen.0010082.st003

X. Zhang, H. Hense, A. J. Riegger, and H. Schunkert, Association of arginine vasopressin and arterial blood pressure in a population-based sample, Journal of Hypertension, vol.17, issue.3, pp.319-324, 1999.
DOI : 10.1097/00004872-199917030-00003

M. K. Husain, A. G. Frantz, F. Ciarochi, and A. G. Robinson, Nicotine-Stimulated Release of Neurophysin and Vasopressin in Humans, The Journal of Clinical Endocrinology & Metabolism, vol.41, issue.6, pp.1113-1117, 1975.
DOI : 10.1210/jcem-41-6-1113

J. W. Rowe, A. Kilgore, and G. L. Robertson, EVIDENCE IN MAN THAT CIGARETTE SMOKING INDUCES VASOPRESSIN RELEASE VIA AN AIRWAY-SPECIFIC MECHANISM, The Journal of Clinical Endocrinology & Metabolism, vol.51, issue.1, pp.170-172, 1980.
DOI : 10.1210/jcem-51-1-170

P. Chiodera, R. Volpi, L. Capretti, G. Speroni, S. Necchi-ghiri et al., Abnormal effect of cigarette smoking on pituitary hormone secretions in insulin-dependent diabetes mellitus, Clinical Endocrinology, vol.46, issue.3, pp.351-357, 1997.
DOI : 10.1046/j.1365-2265.1997.1470945.x

S. R. Orth and E. Ritz, The renal risks of smoking: an update, Current Opinion in Nephrology and Hypertension, vol.11, issue.5, pp.483-488, 2002.
DOI : 10.1097/00041552-200209000-00002